MedTrace Logo

Treatment of Diabetic Foot Ulcers With AUP1602-C

NCT04281992 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-09-28

No results posted yet for this study

Summary

This is a two-part phase 1/2A study performed in diabetic foot ulcer (DFU) patients with chronic non-healing wounds to investigate the safety and efficacy of AUP1602-C.

Conditions

  • Diabetic Foot Ulcer

Interventions

BIOLOGICAL

AUP1602-C

AUP1602-C is topically applied on chronic wounds and covered by wound dressing.

Sponsors & Collaborators

  • Aurealis Oy

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2023-03-20
Completion
2023-03-20

Countries

  • Germany
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281992 on ClinicalTrials.gov